A Phase I Randomized Trial of Topical Insulin for Glaucoma: Safety and Efficacy Outcomes.
Saludares Mariella, Wennberg-Smith Zachary, Beykin Gala, Khatib Tasneem Z, Nunez Mariana, Wang QianQian et al.
Topical insulin for glaucoma was safe and well-tolerated, causing a reversible increase in retinal nerve fiber layer thickness. This suggests a pharmacodynamic effect, warranting further study for neuroprotection.